Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries.

Clin Epidemiol · 2020 · PMC7200224 · PMID 32431551

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a small trendno p-value reported

In Finland, a small trend towards more non-severe uncontrolled hypertension persisted after DHPC dissemination, but this was somewhat counter-balanced by a drop in the level directly after DHPC dissemination.

also in 722 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.